Prevalence of antibodies to respiratory syncytial virus in various populations in Israel.
A preliminary study on the prevalence of antibodies to respiratory syncytial virus (RSV) in individuals of various age-groups was carried out. In healthy infants aged 6 to 12 months, the prevalence was 27%. It increased to 37 and 54% in children aged 1 to 2 and 2 to 4 years, respectively. The prevalence reached 78% in healthy individuals who were more than 20 years old, including pregnant women. Significant levels of specific antibodies were detected in 59% of children aged 6 to 12 months who were hospitalized with respiratory tract illnesses. It appears that acquisition of antibodies to RSV in our population occurs relatively later in life than in other Western countries.
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005312:Fetal Blood / Q000276:immunology; D006801:Humans; D007223:Infant; D007557:Israel; D008297:Male; D011247:Pregnancy; D012136:Respiratory Syncytial Viruses / Q000276:immunology*; D012140:Respiratory Tract Diseases / Q000276:immunology; D012141:Respiratory Tract Infections / Q000276:immunology; D010253:Respirovirus Infections / Q000453:epidemiology / Q000276:immunology; D012698:Serologic Tests
D000914:Antibodies, Viral